NQWM
NUVB icon

Northwest Quadrant Wealth Management’s Nuvation Bio NUVB Stock Holding History

Northwest Quadrant Wealth Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$61.7K Hold
10,855
– – 0.01% 77
2026
Q1 		$46.6K Hold
10,855
– – 0.01% 67
2025
Q4 		$97.3K Hold
10,855
– – 0.02% 71
2025
Q3 		$40.2K Buy
+10,855
New +$29.6K 0.01% 74

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Northwest Quadrant Wealth Management's NUVB Position: Q2 2026 in Review

Northwest Quadrant Wealth Management held its Nuvation Bio (NUVB) position steady in Q2 2026 at 10,855 shares worth $61.7K. The position accounts for 0.01% of the portfolio, ranked #77.

Northwest Quadrant Wealth Management first reported a position in NUVB in Q3 2025 and has held it in 4 quarters since. The position peaked at $97.3K in Q4 2025. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Northwest Quadrant Wealth Management held 10,855 shares of Nuvation Bio worth $61.7K as of Q2 2026.
  • Northwest Quadrant Wealth Management left its Nuvation Bio share count unchanged in Q2 2026.
  • Nuvation Bio made up 0.01% of Northwest Quadrant Wealth Management's portfolio in Q2 2026, its #77 holding.
  • Northwest Quadrant Wealth Management first reported a position in Nuvation Bio in Q3 2025 and has held it in 4 quarters since.
  • Northwest Quadrant Wealth Management's Nuvation Bio position peaked at $97.3K in Q4 2025.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Northwest Quadrant Wealth Management's 13F filing for Q2 2026, filed 13 Aug 2026.